Paediatric gynaecology

Published on 23/06/2015 by admin

Filed under Emergency Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1363 times

15.1 Paediatric gynaecology

Prepubescent gynaecology

Vulvovaginitis

This is the most common gynaecological problem in childhood, usually occurring in girls aged between 2 years and prior to the onset of puberty.1,2 Most vulvovaginitis in this age group is non-infectious in origin and results from irritation of the vaginal and vulval skin, particularly where there is contact between the labial surfaces.2,3 Factors that contribute to genital inflammation include the vaginal and vulval skin of children being thin and atrophic due to low oestrogens and therefore easily irritated. In addition, lack of protective labial hair and fat pads as well as moisture from wet swimming costumes, obesity and poor hygiene may play a role.24 Additionally, the presence of bowel flora, which is the normal flora in the atrophic vagina, may contribute to skin irritation and the other related common symptom of offensive smell.

Infectious vulvovaginitis is less common and is due to an overgrowth of one organism, for example Group A Streptococcus, Staphylococcus, enterococci and Escherichia coli. In this instance, profuse discharge is usually present with marked skin inflammation, often beyond the contact surfaces of the labia.3 Isolation of an organism that has strong sexual transmission, such as Neisseria gonorrhoeae or Chlamydia trachomatis, generally indicates sexual abuse or sexual activity and therefore warrants further investigation.3,4

Lichen sclerosis is an uncommon condition of unknown aetiology. It may present in childhood with vulval irritation, pruritus, dysuria or bleeding.1,2 Examination reveals pale atrophic patches on the labia and perineum. The patches can be extensive and coalesce, and with scratching lead to chronic inflammation and purpuric haemorrhage into the skin. The condition usually persists with intermittent exacerbations. Most resolve before puberty although some may continue to have problems into adult life.5

Eczema may contribute to the symptoms of vulvovaginitis with the addition of itch. In these cases eczema is usually present elsewhere on the body and can be superimposed on the irritation due to the discharge.

Foreign bodies are a potential cause for a persistent, unresolving, often bloodstained offensive discharge.

Candida is very uncommon in the prepubertal girl unless there has been significant antibiotic use or they are still in nappies.2,4 (Thrush thrives in an oestrogenised environment, not in the atrophic setting.) In this age group, recurrent or unexplained candida requires exclusion of diabetes mellitus or other causes of diminished immune function.

Examination

A general examination including sexual development is required. Perineal, vulval and introital examination may be required for the above conditions. Attempts must be made to ensure it is not a traumatic event for the child. The perineum is best examined either with the girl supine with heels together and knees flexed and hips abducted or in the lateral position with knees drawn up to the chest.6 Vaginal examination is inappropriate in paediatric patients and usually provides little further information. Specific external examination of the perineum usually reveals mucoid discharge and reddened introitus, particularly on the contact surfaces between the labia.

The presence of a profuse discharge or marked skin inflammation, especially if it extends beyond the contact surfaces of the labia, suggests an infectious cause. An offensive discharge can occur with vulvovaginitis or foreign body. A bloody discharge can occur with vulvovaginitis (particularly with Shigella or Group A streptococci).6 The presence of perianal excoriation suggests pinworm.

Management

Vulvovaginitis

Management consists of:

Rarely, if the problem persists, further action may be required. The natural history of vulvovaginitis is for recurrences to occur up until the age when oestrogenisation begins. If a primary bacterial cause is suspected, cultures should be taken and treatment commenced with the appropriate antibiotics, e.g. initial amoxicillin, and adjusted when culture results are available.

Where itch is a dominant symptom consider:

Vaginal bleeding

Adolescent gynaecology

History

Diagnosis can often be suspected from the history and the appearance of the discharge.

Abnormal vaginal bleeding

Introduction

Abnormal vaginal bleeding may be caused by a complication of pregnancy, trauma, infection or it may be secondary to contraceptive use. The most common causes of heavy vaginal bleeding are anovulatory bleeding or an underlying haematological condition.11

Menstrual cycles in adolescents are often anovulatory due to the gradual maturation of the hypothalamic–pituitary–ovarian axis, which can take up to 5 years after the menarche.1114 Anovulatory or dysfunctional uterine bleeding generally presents as irregular, often heavy, blood loss. Anovulatory bleeding may result from a relative deficiency of either oestrogen or progesterone. Relative oestrogen deficiency is more common in thin young women who have just commenced their menstrual cycles. The relative oestrogen deficiency results in a thin, atrophic endometrium, which can bleed profusely.

In girls with higher endogenous oestrogen levels, anovulatory menstrual cycles are more likely to result in a relative progesterone deficiency due to failure of the luteal phase. In this case the unopposed oestrogen results in thickening of the endometrial lining, which can bleed erratically.

Menorrhagia, whether associated with ovulatory or anovulatory cycles, may be a marker of systemic illness. Up to 20% of patients admitted with menorrhagia have been found to have an underlying haematological disease, the most common of which is a coagulopathy, half of which are von Willebrand’s disease and the other half due to platelet problems or dysfunction – other factor deficiencies are very rare.11,14

Chronic untreated menorrhagia may also present with signs and symptoms of anaemia.

Management

Heavy bleeding, either acute or chronic, should be treated with fluid and blood products as clinically indicated.

Oestrogens and progestins are generally used in the management of anovulatory bleeding. Suggested regimens vary with respect to the route of administration, the dose and the type of hormone used. Currently there is no convincing evidence in favour of any particular regimen.16

For both the acute and non acute bleed tranexamic acid should be used. This can be used in combination with hormonal approaches. If using progestogens first line, regimens include oral norethisterone 5–10 mg every 2 hours for four doses, followed by 5 mg two to three times a day for 14 days.8 Commencing the oral contraceptive pill once the bleeding has ceased may be sensible, as cessation of the progestogens will almost invariably result in bleeding recommencing.

Alternatively, treatment may include oral conjugated oestrogens 0.625–1.25 mg every 4–6 hours or oral oestradiol 1–2 mg every 4–6 hours until the bleeding stops, which is usually about 24 hours. The dose is then reduced to once or twice daily. Intravenous conjugated oestrogens are no longer available in Australia and have been associated with thromboembolic complications, consequently oral regimens are generally preferred.17 This approach is worth taking when progestogens have already been used and failed, but can be used first line. Again, the oral contraceptive pill should be commenced for ongoing control, particularly if there is a need to allow some time before further menses in the context of a low haemoglobin. Supplement with iron therapy.

Menorrhagia, in the absence of a coagulation disorder or other underlying pathology, can be treated with non-steroidal anti-inflammatory agents or tranexamic acid, which reduce the menstrual loss by 33% and 50% respectively,11,18 or, alternatively, low-dose oral contraceptive therapy.12

Pelvic pain

History

A general gynaecological history should be taken, with particular note made of the relationship of the pain to the menstrual cycle. History should also include the nature of onset of the pain and a history of similar episodes. The pain of dysmenorrhoea, Mittelschmertz, endometriosis and imperforate hymen may be cyclical. However, they may also present during the first episode or as an unusually severe exacerbation. An ectopic pregnancy is not excluded by the history of a recent menstrual period.

References

1 Mroueh J., Muram D. Common problems in paediatric gynaecology: New developments. Curr Opin Obstet Gynecol. 1999;11(5):463-466.

2 Fiorillo L. Therapy of paediatric genital diseases. Dermatol Ther. 2004;17:117-128.

3 Jaquiery A., Styianopoulos A., Hogg G., Grover S. Vulvovaginitis: Clinical features, aetiology, and microbiology of the genital tract. Arch Dis Child. 1999;81:64-67.

4 Farrington P. Paediatric vulvo-vaginitis. Clin Obstet Gynaecol. 1997;40(1):135-140.

5 Fischer G. Vulval disease in pre-pubertal girls. Australas J Dermatol. 2001;42:225-236.

6 Quint E. Vaginal bleeding and discharge in the paediatric and adolescent age groups. In: Pearlman M., Tintinalli J., editors. Emergency care of the woman. New York: McGraw-Hill; 1998:395-407.

7 Grover S. Gynaecological conditions. In: Smart, editor. Paediatric handbook. 6th ed. Melbourne: Blackwell Science Asia; 2000:342-350.

8 Mackay E., Beischer N., Pepperell R., Wood C. Illustrated textbook of gynaecology, 2nd ed. London: WB Saunders; 2000.

9 Blake D.R., Fletcher K., Joshi N., Emans S.J. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Paediatr Adolesc Gynaecol. 2003;16(1):25-30.

10 Therapeutic Guidelines. Antibiotic Version 13. Therapeutics Guidelines Ltd; 2006.

11 Grover S. Bleeding disorders and heavy menses in adolescents. Curr Opin Obstet Gynecol. 2007;19:415-419.

12 Sandofilippo J.S., Lara-Torre E. Adolescent gynaecology. Obstet Gynaecol. 2009;113:935-947.

13 Apter D., Viinikka L., Vihko R. Hormonal pattern of adolescent menstrual cycles. J Clin Endocrinol Metab. 1978;47(5):944-954.

14 Claessens E.A., Cowell C.A. Acute adolescent menorrhagia. Am J Obstet Gynecol. 1981;139(3):277-280.

15 Duflos-Cohade C., Amandruz M., Thibaud E. Pubertal metrorrhagia. J Paediatr Adolesc Gynaecol. 1996;9(1):16-20.

16 Hickey M., Higham J., Fraser I.S. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation. In: Cochrane Review. The Cochrane Library. Oxford: Update software; 2003. Issue 3

17 Richlin S.S., Rock J.A. Abnormal uterine bleeding. In: Carpenter S.E.K., Rock J.A., editors. Paediatric and adolescent gynaecology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000:207-224.

18 Prentice A. Fortnightly review: Medical management of menorrhagia. Br Med J. 1999;319:1343-1345.

19 Hann L.E., Hall D.A., Black E.B., Ferrucci J.T. Mittelschmerz. Sonographic demonstration. JAMA. 1979;241(25):2731-2732.

20 Ben-Ami M., Perlitz Y., Haddad S. The effectiveness of spectral and color Doppler in predicting ovarian torsion. A prospective stud. Eur J Obstet Gynecol Reprod Biol. 2002;104(1):64-66.

21 Grover S. Pelvic pain in the female adolescent patient. Aust Fam Phys. 2006;35(11):850-853.

22 Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR. 2002;51(NoRR-6):32-36. 69–71

23 Arbel-Derowe Y., Tepper R., Rosen D.J., et al. The contribution of pelvic ultrasound to the diagnostic process in paediatric and adolescent gynaecology. J Paediatr Adolesc Gynaecol. 1997;10:3-12.

24 Sanfilippo J., Erb T. Evaluation and management of dysmenorrhoea in adolescents. Clin Obstet Gynecol. 2008;51(2):257-267.

25 Bolton P., Del Mar C., O’Connor V. Exercise for primary dysmenorrhoea (Protocol for a Cochrane Review). In: The Cochrane Library. Oxford: Update Software; 2003. Issue 3

26 Hemsel D.L., Ledger W.J., Martens M., et al. Concerns regarding the Centers for Disease Control’s published guidelines for pelvic inflammatory disease. Clin Infect Dis. 2001;32:103-107.